Novo Nordisk: Switch To Weekly Ozempic Has Begun, Biopharma M&A Sought

 
• By Sten Stovall
  
Diabetes
Effective launch of the once-weekly GLP-1 Ozempic is vital for the future of Novo Nordisk • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business